1. Home
  2. CETX vs VYNE Comparison

CETX vs VYNE Comparison

Compare CETX & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cemtrex Inc.

CETX

Cemtrex Inc.

HOLD

Current Price

$1.42

Market Cap

17.5M

Sector

Technology

ML Signal

HOLD

Logo VYNE Therapeutics Inc.

VYNE

VYNE Therapeutics Inc.

HOLD

Current Price

$0.59

Market Cap

19.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CETX
VYNE
Founded
1998
2003
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.5M
19.0M
IPO Year
1998
2018

Fundamental Metrics

Financial Performance
Metric
CETX
VYNE
Price
$1.42
$0.59
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
1.0M
418.2K
Earning Date
02-13-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$76,488,088.00
$524,000.00
Revenue This Year
$20.41
N/A
Revenue Next Year
N/A
$16.67
P/E Ratio
N/A
N/A
Revenue Growth
14.39
6.29
52 Week Low
$1.36
$0.28
52 Week High
$42.60
$2.94

Technical Indicators

Market Signals
Indicator
CETX
VYNE
Relative Strength Index (RSI) 36.98 68.94
Support Level $1.37 $0.55
Resistance Level $1.60 $0.57
Average True Range (ATR) 0.15 0.02
MACD 0.02 -0.00
Stochastic Oscillator 10.38 91.01

Price Performance

Historical Comparison
CETX
VYNE

About CETX Cemtrex Inc.

Cemtrex Inc is a multi-industry technology company. It has expanded into a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security systems. The company's operating segment includes the Security segment and the Industrial Services segment. The security segment provides end-to-end security to all industrial, corporate, and governmental security via its owned subsidiary, Vicon. Whereas the AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in-plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment, and from the USA. It also operates UK, USA, and Other.

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

Share on Social Networks: